The following has been taken directly from Standard for the Uniform Scheduling of Drugs & Poisons written by the Australian Government. (Australian Health Ministers' Advisory Council).
Schedule 1 -
Schedule 2 - Poisons for therapeutic use that should be available to the public only from pharmacies; or where there is no pharmacy service available, from persons licensed to sell Schedule 2 poisons.
Schedule 3 - Poisons for therapeutic use that are dangerous or are so liable to abuse as to warrant their availability to the public being restricted to supply by pharmacists or medical, dental or veterinary practitioners.
Schedule 4 - Poisons that should, in the public interest, be restricted to medical, dental or veterinary prescription or supply, together with substances or preparations intended for therapeutic use, the safety or efficacy of which requires further evaluation.
Schedule 5 - Poisons of a hazardous nature that must be readily available to the public but require caution in handling, storage and use.
Schedule 6 - Poisons that must be available to the public but are of a more hazardous or poisonous nature than those classified in Schedule 5.
Schedule 7 - Poisons which require special precautions in manufacturing, handling, storage or use, or special individual regulations regarding labeling or availability.
Schedule 8 - Poisons to which the restrictions recommended for drugs of dependence by the 1980 Australian Royal Commission of Inquiry into Drugs should apply.
Schedule 9 - Poisons which are drugs of abuse, the manufacture, possession, sale or use of which should be prohibited by law except for amounts which may be necessary for medical or scientific research conducted with the approval of Commonwealth and/or State or Territory Health Authorities.
There are also Appendices of which Appendix C is particularly relevant to Australian Herbalists ...
Appendix C - Substances other than those included in Schedule 9, of such danger to health as to warrant prohibition of sale, supply and use.
Atropa belladona (containing <0.25% belladonna alkaloids)
Datura spp. (containing <0.25% Datura alkaloids)
Datura stramonium (containing <0.25% stramonium alkaloids, except for smoking or burning)
Hyoscyamus (containing <0.25% hyoscyamine)
Lobelia inflata except smoking or burning
Quinine except in preparations containing < 40mg/l or 40mg/kg
Aconitum spp. for therapeutic use
Adonis vernalis for therapeutic use
Ammi visnaga for therapeutic use
Atropa belladona for therapeutic use, except when in S2
Brugmansia spp. for therapeutic use
Colchicum autumnale for therapeutic use
Convallaria spp. for therapeutic use
Coumarin for therapeutic use
Datura spp. except when in S2
Datura stramonium except when in S2 or for smoking or burning
Digitalis lanata, D. purpurea for therapeutic use
Lobelia inflata except when in S2 or for smoking or burning
Mandragara officinalis for therapeutic use
Nerium oleander for therapeutic use
Rauvolfia spp. for therapeutic use
Strophanthus spp. for therapeutic use
Strychnos nux-vomica for therapeutic use
Tanacetum vulgare except preparations containing <0.8% of oil of tansy
Symphytum officinalis - must have a warning label when sold for topical use (internal use is Appendix C!)
Abrus precatorius (Jequirity) seed or root for therapeutic use
Amygdalin for therapeutic use
Anchusa officinalis for therapeutic use
Aristolochia spp. for therapeutic use
Borago officinalis (Borage) for therapeutic use except the fixed oil derived from the seeds of Borago off.
Cacalia spp. for therapeutic use
Crotalaria spp. for therapeutic use
Croton tiglium for therapeutic use
Cynoglossum officinalis for therapeutic use
Cynoglossum spp. for therapeutic use 'except when separately specified in this appendix'
Eupatorium cannabinum (Hemp Agrimony) for therapeutic use
Farfugium japonicum for therapeutic use
Heliotropium ramosissimum for therapeutic use
Heliotropium spp. for therapeutic use 'except when separately specified in this appendix'
Heliotropium supinum for therapeutic use
Juniperis sabina for therapeutic use
Ligularia dentata for therapeutic use
Petasites japonicum for therapeutic use
Petasites spp. for therapeutic use 'except when separately specified in this appendix'
Pteridium aquilinium for therapeutic use
Pteridium spp. for therapeutic use 'except when separately specified in this appendix'
Pulmonaria spp. for therapeutic use
Senecio cannabifolius for therapeutic use
Senecio jacobaea for therapeutic use
Senecio longilobus for therapeutic use
Senecio numorensis fuchsii for therapeutic use
Senecio spp. for therapeutic use 'except when separately specified in this appendix'
Symphytum spp. (Comfrey) for therapeutic use except when included in schedule 5
Trichodesma africana for therapeutic use
Tussilago farfara (Coltsfoot) for therapeutic use
Copyright © The Australian
Naturopathic Network 1998-2002. All rights reserved.
Revised: May 18, 2002 .